European Society of Human Genetics

European Society of Human Genetics

@eshg.bsky.social

The ESHG is a non-profit organization. Its aims are to promote research in basic and applied human and medical genetics, to ensure high standards in clinical practice and to facilitate contacts between all persons who share these aims.

862 followers53 following319 posts

Phenome-wide map of 467k+ UK Biobank genomes highlights massive impact of structural variants (SVs) on human health: 🔹 37,063 SV-trait associations across 18k+ phenotypes & proteins 🔹 Rare SVs exert powerful effects on disease risk 🔹 82%+ of SVs hidden from prior copy-number studies buff.ly/qFaqvuD

What can rare disease teach us about the noncoding genome? A new Review explores disease-causing variants in promoters, enhancers and silencers, their mechanisms of action, and the challenges of interpreting regulatory variation in human disease. 🔗https://www.nature.com/articles/s41588-026-02743-3

🧬 Repeat-expansion disorders remain challenging to resolve with conventional approaches. New Perspective explores how LRS can capture repeat size, composition, mosaicism and methylation - and its growing role in research and clinical diagnostics. 👉https://www.nature.com/articles/s41588-026-02694-9

🧬 Improving genetic diagnosis in rare neurological diseases 31 experts from 11 European countries agreed on 27 recommendations for NGS-based genetic testing, supporting high-quality harmonised diagnostics. 👉https://www.nature.com/articles/s41431-026-02198-4

📢 Out now in EJHG! 🧬 Episignature analysis improved classification of CHD8 missense VUS. Combined with molecular modelling and detailed phenotyping, it supports a loss- or reduced-function mechanism for pathogenic CHD8 missense variants. 👉https://www.nature.com/articles/s41431-026-02209-4

Genomic newborn screening could enable earlier diagnosis - but it may also create uncertainty, overdiagnosis and pressure on healthcare resources. A new Comment considers how to balance benefits and harms while strengthening diagnostic services. 👉 www.nature.com/articles/s41...

nature.comReducing the diagnostic odyssey in rare disease: why screening is not the only answer - Nature MedicineThe timely detection of rare diseases is crucial, and using a range of approaches will be key to reducing the diagnostic odyssey.

🧬 New studies show how SVs downstream of FOXG1 can disrupt its regulation and contribute to a FOXG1-like NDD. Together, they reveal distinct regulatory loci and provide new insight into the locus’s 3D organisation. 👉https://buff.ly/UVhWtWk 👉https://buff.ly/Nvidv1E

ESHG Mentorship scheme 2026 We want to thank the Mentors: Reedik Mägi - University of Tartu, Estonia Joris A Veltman - University of Edinburgh, UK Sarah Stewart - University of Manchester, UK Jean-Laurent Casanova - Imagine Institute, France Kristiina Tammimies - Karolinska Institutet, Sweden